Press Releases 3 Investor Relations Press Releases Events Presentations Press Releases Year None202420232022202120202019 Apr 18, 2024 DermTech to Explore Strategic Alternatives and Implement Restructuring Plan Apr 01, 2024 DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 08, 2024 DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology Feb 29, 2024 DermTech Reports Fourth-Quarter 2023 Financial Results Feb 13, 2024 DermTech Announces Release Date for Fourth-quarter 2023 Financial Results Jan 31, 2024 DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations Jan 18, 2024 DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types Jan 16, 2024 DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay Jan 08, 2024 DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT) Investor Tools Print Email Page Email Alerts RSS Feeds Contact IR
Press Releases Year None202420232022202120202019 Apr 18, 2024 DermTech to Explore Strategic Alternatives and Implement Restructuring Plan Apr 01, 2024 DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Mar 08, 2024 DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology Feb 29, 2024 DermTech Reports Fourth-Quarter 2023 Financial Results Feb 13, 2024 DermTech Announces Release Date for Fourth-quarter 2023 Financial Results Jan 31, 2024 DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations Jan 18, 2024 DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types Jan 16, 2024 DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay Jan 08, 2024 DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)
Mar 08, 2024 DermTech Presents Research Abstracts at the 2024 American Academy of Dermatology (AAD) Annual Meeting and New Research Published in the Journal of Investigative Dermatology
Jan 31, 2024 DermTech Announces Additional Restructuring Actions to Focus on Revenue Growth and Streamline Operations
Jan 18, 2024 DermTech Announces Positive Topline Results From a Study Evaluating the DermTech Melanoma Test (DMT) Across All Skin Types
Jan 16, 2024 DermTech Simplifies the DermTech Melanoma Test (DMT) by Discontinuing the Optional TERT Add-on Assay
Jan 08, 2024 DermTech Announces Positive Topline Results From Trust 2 Study Evaluating the DermTech Melanoma Test (DMT)